| Literature DB >> 23526787 |
Jane Wang1, Kyle G Boutin, Omar Abdulhadi, Lyndia D Personnat, Tarek Shazly, Robert Langer, Colleen L Channick, Jeffrey T Borenstein.
Abstract
Airway stents are often used to maintain patency of the tracheal and bronchial passages in patients suffering from central airway obstruction caused by malignant tumors, scarring, and injury. Like most conventional medical implants, they are designed to perform their functions for a limited period of time, after which surgical removal is often required. Two primary types of airway stents are in general use, metal mesh devices and elastomeric tubes; both are constructed using permanent materials, and must be removed when no longer needed, leading to potential complications. This paper describes the development of process technologies for bioresorbable prototype elastomeric airway stents that would dissolve completely after a predetermined period of time or by an enzymatic triggering mechanism. These airway stents are constructed from biodegradable elastomers with high mechanical strength, flexibility and optical transparency. This work combines microfabrication technology with bioresorbable polymers, with the ultimate goal of a fully biodegradable airway stent ultimately capable of improving patient safety and treatment outcomes.Entities:
Keywords: airway stents; biodegradable; elastomer; implant; polymer
Mesh:
Substances:
Year: 2013 PMID: 23526787 PMCID: PMC4082816 DOI: 10.1002/adhm.201200348
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933